Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
16-30 of 1758 results
Teva, IBM to develop cognitive technologies for drug repurposing
By PBR Staff Writer
Teva Pharmaceutical Industries and IBM have expanded their worldwide e-health alliance with new projects designed to discover new uses for existing drugs and advance chronic disease management.
Automation > IT & Software > News
IBM makes Watson technology available to US employees fighting cancer
IBM is offering its Watson technology to its US employees to help them identify appropriate cancer treatments and options for clinical trials.
Automation > IT & Software > News
Nexus BioPharma signs deal with TransChem for kinase inhibition technology
Nexus BioPharma has signed an agreement to license TransChem's transition state chemistry technology for kinase inhibition.
Automation > IT & Software > News
Codexis completes final phase in transfer of CodeEvolver technology to Merck
Codexis has completed the second and final phase in the transfer of its CodeEvolver protein engineering platform technology to Merck, known as MSD outside the US and Canada, under a non-exclusive licensing agreement.
Automation > IT & Software > News
Bayer, DelSiTech partner to develop new drug delivery technology for ophthalmology
Bayer and DelSiTech have partnered to develop innovative drug delivery technology for ophthalmology.
Automation > IT & Software > News
AstraZeneca selects LLamasoft as supply chain design technology partner
AstraZeneca has selected LLamasoft’s Supply Chain Guru and Data Guru as tools of choice for supply chain modelling.
Automation > IT & Software > News
Ligand Pharmaceuticals signs OmniAb license deal with TeneoBio
Ligand Pharmaceuticals has entered into a worldwide license agreement with Menlo Park, CA-based TeneoBio.
Automation > IT & Software > News
Pfizer launches app to help patients manage depression
Pfizer has launched a new app, Moodivator, to help motivate and encourage the millions of adults who experience depression.
Automation > IT & Software > News
EPAM, Sinequa partner to address cognitive search & analytics challenges in pharma industry
EPAM Systems and Sinequa have partnered to deliver search and analytics solutions for data-driven Global 2000 companies in the pharmaceutical industry.
Automation > IT & Software > News
Merck introduces new gene editing technology to modify CHO cell lines
Merck has introduced a gene editing technology that can modify CHO cell lines to be resistant to minute virus of mice (MVM), a common contamination threat that remains despite the shift to chemically defined, animal component-free manufacturing processes.
Automation > IT & Software > News
Compugen enhances LINKS computational platform
Compugen disclosed that its LINKS computational platform, initially designed for the characterization and differentiation of existing novel drug target candidates, has been enhanced to include the in silico discovery of new immuno-oncology drug targets, with a specific focus on the discovery of myeloid targets within the tumor microenvironment (TME).
Automation > IT & Software > News
Daiichi Sankyo chooses Veeva Vault to streamline submissions, eTMF, and quality management
Daiichi Sankyo has selected Veeva Systems' Veeva Vault eTMF, Veeva Vault QualityDocs, and Veeva Vault Submissions to unify content management throughout its research and development (R&D) operations worldwide.
Automation > IT & Software > News
Eleven Biotherapeutics completes exclusive licensing deal for IL-6 antagonist antibody technology
Eleven Biotherapeutics, a biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, announced the effectiveness of the exclusive licensing deal with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. (Roche).
Automation > IT & Software > News
Genmab signs commercial license deal with Gilead for DuoBody technology
Genmab has entered an agreement to grant Gilead Sciences an exclusive license and an option on a second exclusive license, to use the DuoBody technology platform to create and develop bispecific antibody candidates for a therapeutic program targeting HIV.
Automation > IT & Software > News
Lantern Pharma signs deal to evaluate BioNumerik’s Tavocept
Lantern Pharma has entered into an exclusive agreement to evaluate BioNumerik Pharmaceuticals' Tavocept for human therapeutic indications using Lantern’s 5-M theranostic platform.
Automation > IT & Software > News
16-30 of 1758 results